Guideliner V3 Catheter
Payments companies reported to CMS as associated with Guideliner V3 Catheter. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Guideliner V3 Catheter, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Guideliner V3 Catheter
These are the largest totals companies reported as associated with Guideliner V3 Catheter. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Rhian Davies | York, PA | Cardiovascular Disease | $32,148.11 |
| Anthony Spaedy | Kansas City, KS | Interventional Cardiology | $31,273.28 |
| Garrett Wong | Sacramento, CA | Cardiovascular Disease | $13,029.27 |
| Brian Bergmark | Boston, MA | Cardiovascular Disease | $10,007.72 |
| Reza Nazari | Turlock, CA | Cardiovascular Disease | $97.75 |
| William Harris | Newport News, VA | Interventional Cardiology | $55.42 |
| Edward Chu | Newport News, VA | Interventional Cardiology | $35.46 |
| Ashley Ferguson | San Marcos, TX | Family | $21.95 |
| Ernest Zichal | Newport News, VA | Vascular Surgery | $19.96 |
| Partha Manchikalapudi | Virginia Beach, VA | Interventional Cardiology | $19.09 |
Prescribed Guideliner V3 Catheter?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.